Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Conley

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Current Opinion in Oncology|April 18, 2009
Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospectsSreenivasa R Chandana, Barbara A Conley
Expert Review of Anticancer Therapy|April 12, 2008
Salivary gland cancers: current treatments, molecular characteristics and new therapiesSreenivasa R Chandana, Barbara A Conley
Disease Markers|August 24, 2004
Prognostic and predictive markers in cancerBarbara A Conley, Sheila E Taube
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Detection of prostate cancer and predicting progression: current and future diagnostic markersJames V Tricoli, Mason Schoenfeldt, Barbara A Conley
Cancer|July 11, 2006
Targeting epigenetic abnormalities with histone deacetylase inhibitorsBarbara A Conley, John J Wright, Shivaani Kummar
Journal of Cellular Biochemistry|November 3, 2007
Novel biochemical pathways of endoglin in vascular cell physiologyCarmelo Bernabeu, Barbara A Conley, Calvin P H Vary
Head & Neck|July 30, 2014
Designing biomarker studies for head and neck cancerKelly Y Kim, Lisa M McShane, Barbara A Conley
Drugs in R&D|November 8, 2008
Histone deacetylation : an attractive target for cancer therapy?Anas Al-Janadi, Sreenivasa R Chandana, Barbara A Conley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Clinical trial designs for predictive marker validation in cancer treatment trialsDaniel J Sargent, Barbara A Conley, Carmen Allegra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Development and use of integral assays in clinical trialsRichard L Schilsky, James H Doroshow, Michael Leblanc, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Current Opinion in Oncology|April 18, 2009
Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospectsSreenivasa R Chandana, Barbara A Conley
Expert Review of Anticancer Therapy|April 12, 2008
Salivary gland cancers: current treatments, molecular characteristics and new therapiesSreenivasa R Chandana, Barbara A Conley
Disease Markers|August 24, 2004
Prognostic and predictive markers in cancerBarbara A Conley, Sheila E Taube
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Detection of prostate cancer and predicting progression: current and future diagnostic markersJames V Tricoli, Mason Schoenfeldt, Barbara A Conley
Cancer|July 11, 2006
Targeting epigenetic abnormalities with histone deacetylase inhibitorsBarbara A Conley, John J Wright, Shivaani Kummar
Journal of Cellular Biochemistry|November 3, 2007
Novel biochemical pathways of endoglin in vascular cell physiologyCarmelo Bernabeu, Barbara A Conley, Calvin P H Vary
Head & Neck|July 30, 2014
Designing biomarker studies for head and neck cancerKelly Y Kim, Lisa M McShane, Barbara A Conley
Drugs in R&D|November 8, 2008
Histone deacetylation : an attractive target for cancer therapy?Anas Al-Janadi, Sreenivasa R Chandana, Barbara A Conley
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Clinical trial designs for predictive marker validation in cancer treatment trialsDaniel J Sargent, Barbara A Conley, Carmen Allegra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Development and use of integral assays in clinical trialsRichard L Schilsky, James H Doroshow, Michael Leblanc, et al.
Pageof 8